Shooting Cancer

31 05, 2021

Utility and use of NGS in clinical oncology: ESMO recommendations for patients with metastatic cancers

Diatech Pharmacogenetics2021-05-31T15:56:48+02:00

2 04, 2021

Europe approves the first anti-PD-L1/L1 therapy for patients with MSI-H/dMMR colorectal cancer

Diatech Pharmacogenetics2021-04-02T16:14:30+02:00

1 03, 2021

A breakthrough for the targeted therapy of RET+ tumours with new selective inhibitors

Diatech Pharmacogenetics2021-03-01T15:25:16+01:00

21 12, 2020

Hope of a cure for cholangiocarcinoma coming from FGFR inhibitors

Diatech Pharmacogenetics2020-12-22T11:57:21+01:00

28 09, 2020

Alpelisib and PIK3CA mutations: a new molecular targeted therapy for breast cancer is approved

Diatech Pharmacogenetics2020-09-28T18:43:55+02:00

29 06, 2020

New European recommendations on DPD testing prior to anticancer therapy with fluoropyrimidines

Diatech Pharmacogenetics2020-06-29T17:33:09+02:00

16 04, 2020

A new therapeutic opportunity treatment of NSCLC: the BRAF V600 mutation

Diatech Pharmacogenetics2020-04-16T17:00:25+02:00